Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Introduction of Re-188 to enhance the inhibiting effect of Bevacizumab for Non-small-cell Lung Cancer

Jie Xiao, Xiao Li, Yanli Li, Hongcheng Shi and Dengfeng Cheng
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1455;
Jie Xiao
1Zhongshan Hospital, Fudan University Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao Li
1Zhongshan Hospital, Fudan University Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanli Li
1Zhongshan Hospital, Fudan University Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongcheng Shi
1Zhongshan Hospital, Fudan University Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dengfeng Cheng
1Zhongshan Hospital, Fudan University Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 1455

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Jie Xiao1,
  2. Xiao Li1,
  3. Yanli Li1,
  4. Hongcheng Shi1 and
  5. Dengfeng Cheng1
  1. 1Zhongshan Hospital, Fudan University Shanghai China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to May 2025

AbstractFullPdf
May 2016400
Jun 20162200
Jul 2016700
Aug 20161100
Sep 2016500
Oct 2016300
Nov 2016800
Dec 2016200
Jan 2017200
Feb 20173900
Mar 2017500
Apr 2017500
May 2017700
Jun 2017300
Jul 2017600
Aug 2017400
Sep 20171500
Oct 2017300
Nov 2017300
Dec 2017100
Jan 2018100
Feb 2018100
Mar 2018100
May 2018100
Aug 2018300
Nov 2018200
Dec 2018200
Jan 2019200
Apr 2019100
Jun 2019100
Jul 2019100
Aug 2019100
Nov 2019100
Dec 2019100
Feb 2020300
Mar 2020100
May 2020100
Aug 2020300
Dec 2020400
Feb 2021900
Mar 2021700
Apr 2021700
May 2021500
Jun 2021300
Jul 2021400
Aug 2021300
Sep 2021500
Oct 2021100
Nov 2021600
Dec 2021100
Jan 2022400
Feb 2022400
Mar 2022300
Apr 2022400
May 2022300
Jun 2022300
Jul 2022200
Aug 2022400
Sep 2022300
Oct 2022200
Nov 2022200
Dec 2022100
Jan 2023700
Feb 2023100
Mar 2023900
Apr 2023200
May 2023100
Jun 2023200
Jul 2023300
Aug 2023300
Sep 2023100
Oct 2023400
Nov 2023400
Dec 2023100
Jan 2024600
Feb 2024200
Mar 2024100
Apr 2024300
May 2024100
Jun 2024400
Jul 2024100
Aug 20241400
Sep 20241200
Oct 2024200
Nov 2024200
Dec 2024800
Feb 2025700
Mar 2025200
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Introduction of Re-188 to enhance the inhibiting effect of Bevacizumab for Non-small-cell Lung Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Introduction of Re-188 to enhance the inhibiting effect of Bevacizumab for Non-small-cell Lung Cancer
Jie Xiao, Xiao Li, Yanli Li, Hongcheng Shi, Dengfeng Cheng
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1455;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Introduction of Re-188 to enhance the inhibiting effect of Bevacizumab for Non-small-cell Lung Cancer
Jie Xiao, Xiao Li, Yanli Li, Hongcheng Shi, Dengfeng Cheng
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1455;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Radiopharmaceutical Therapy Posters

  • Therapeutic Effect of I-131-labeled Chitosan Hydrogels on Treatment of Hepatic Cancer: Focused on In vivo Rodent Orthotopic Hepatic Cancer Models
  • Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
  • Difference in thyroid uptake between Astatine-211 and Iodine-123 in normal rats: a comparative study between oral and intravenous administration.
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire